Aug 2026· Journal of Human Centered Technology· Vol 5, pp. 117-128· 0 citations· 43 references
TL;DR
An enhanced deep learning framework that integrated a Transformer-based Generative Adversarial Network (TGAN) with an attention-enhanced ResNet-50 architecture for robust multiclass classification of Cognitively Normal, Mild Cognitive Impairment, and Alzheimer’s Disease MRI images is proposed.
Abstract
Early detection of Alzheimer’s Disease (AD) is essential for timely clinical intervention. However, conventional Magnetic Resonance Imaging-based (MRI-based) diagnostic approaches are often limited by class imbalance, insufficient training data, inter-dataset variability, and inadequate feature extraction capability, which reduce the reliability of early-stage AD identification. This study proposed an enhanced deep learning framework that integrated a Transformer-based Generative Adversarial Network (TGAN) with an attention-enhanced ResNet-50 architecture for robust multiclass classification of Cognitively Normal (CN), Mild Cognitive Impairment (MCI), and Alzheimer’s Disease (AD) MRI images. The TGAN model was employed to generate anatomically realistic synthetic MRI scans to address dataset imbalance and improve feature diversity, while the enhanced ResNet-50 utilized residual learning and attention mechanisms to improve the extraction of discriminative neuroanatomical features associated with disease progression. A comprehensive preprocessing pipeline was applied to standardize MRI data obtained from the ADNI and OASIS datasets. We conducted a series of experiments on the ADNI and OASIS databases. The proposed system demonstrated a classification accuracy of 94.8% on ADNI and 93.6% on OASIS, greatly surpassing baseline models such as ordinary ResNet-50, DenseNet-121, and traditional GAN-augmented CNNs. Ablation investigations further verified the significance of the Transformer-based generator and attention-enhanced residual blocks, each yielding substantial performance enhancements.
An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.
K. V. S. V. Trinadh Reddy, Gundeboyina Srinivasalu, T. V. Rao et al.· Archives of Medical Research· 0 citations
Alzheimer's disease (AD) is a chronic neurodegenerative disease in which early diagnosis is crucial for early intervention and the appropriate management of patients. But the patho-octical changes in early stages, such as mild cognitive impairment (MCI), have been hard to detect with traditional diagnostic methods. Thi...
Tarun Kumar· Natural Resources for Human...· 0 citations
Early and accurate classification of Alzheimer's disease (AD) stages from magnetic resonance imaging (MRI) remains a critical challenge in clinical neuroimaging, particularly for distinguishing early-stage cognitive decline from normal aging. Existing deep learning approaches applied to publicly available augmented MRI...
This study presents a deep learning framework for PD classification from structural brain MRI using six complementary architectures: EfficientNetV2-S, DenseNet-169, ConvNeXt-Small, ViT-B/16, Swin-Small, and MaxViT-Tiny.
In worldwide, Alzheimer's Disease (AD) is one of the leading cause of death and requires earlier diagnosis for timely and effective treatment management. Neuroimaging, particularly Magnetic Resonance Imaging (MRI) provides a promising solution to detect the AD at earlier stages. Timely detection of variations in brain...
Revathi Mohan, Shital S. Mali, Poonguzhali Ilango et al.· Psychiatry research. Neuroim...· 0 citations
Recent progress in AI-driven approaches for AD detection is discussed and the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer's disease is underscored.
Hakar Hasan Rasheed, Naaman Omar Yaseen· Academic Journal of Internat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.